Attention: This platform is in beta mode. Expect some changes and adjustments.

AI Market Mood: Stock Dashboard

ADVM


Fundamental

Company: Adverum Biotechnologies Inc
Sector: Healthcare
Industry: Biotechnology
Country: USA
Exchange: NASD
Index: RUT
P/E: -
EPS (ttm): -6.03
Insider Own: 38.42%
Shs Outstand: 20.80M
Perf Week: -15.48%
Market Cap: 88.61M
Forward P/E: -
EPS next Y: -5.20
Insider Trans: 6.32%
Shs Float: 12.81M
Perf Month: 0.24%
Income: -94.11M
PEG: -
EPS next Q: -1.40
Inst Own: 51.11%
Short Float: 11.57%
Perf Quarter: -9.17%
Sales: 1.00M
P/S: 88.61
EPS this Y: -11.13%
Inst Trans: -9.42%
Short Ratio: 8.49
Perf Half Y: -39.32%
Book/sh: 6.93
P/B: 0.61
EPS next Y Percentage: 8.30%
ROA: -43.66%
Short Interest: 1.48M
Perf Year: -69.33%
Cash/sh: 7.37
P/C: 0.58
EPS next 5Y: 1.40%
ROE: -76.26%
52W Range From: 3.52
52W Range To: 14.16
Perf YTD: -8.78%
Dividend Est.: -
P/FCF: -
EPS past 5Y: 0.36%
ROI: -45.53%
52W High: -69.91%
Beta: 1.00
Dividend TTM: -
Quick Ratio: 5.82
Sales past 5Y: -
Gross Margin: -285.20%
52W Low: 21.02%
ATR (14): 0.49
Dividend Ex-Date: -
Current Ratio: 5.82
EPS Y/Y TTM: 51.95%
Oper. Margin: -11390.00%
RSI (14): 44.67
Volatility W: 13.66%
Volatility M: 10.17%
Employees: -
Debt/Eq: 0.51
Sales Y/Y TTM: -72.22%
Profit Margin: -9411.10%
Recom: 1.50
Target Price: 19.33
Option/Short: Yes / Yes
LT Debt/Eq: 0.43
EPS Q/Q: 60.08%
Payout: -
Rel Volume: 0.88
Prev Close: 3.83
Sales Surprise: -
EPS Surprise: -1.40%
Sales Q/Q: -
Earnings: Mar 26
Avg Volume: 174.59K
Price: 4.26
SMA20: -10.47%
SMA50: -4.99%
SMA200: -31.48%
Trades:
Volume: 153,732
Change: 11.23%

Technical:


Latest News:

Analysts' Top Healthcare Picks: Adverum Biotechnologies (ADVM), Gilead Sciences (GILD) somewhat bullish
ADVM GILD CVRX

Summary: Analysts are bullish on Adverum Biotechnologies (ADVM), Gilead Sciences (GILD), and CVRx (CVRX) in the Healthcare sector.

Full article
2025-02-13T15:11:42Z